Literature DB >> 26148969

Human α-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity.

Zili Xie1, Jing Feng1, Weishan Yang1, Fang Xiang1, Fan Yang1, Yonghui Zhao1, Zhijian Cao1, Wenxin Li1, Zongyun Chen2, Yingliang Wu2.   

Abstract

Defensins form a major family of antimicrobial peptides. Recently, human β-defensin 2 and fungal plectasin were shown to be immune-related potassium voltage-gated channel subfamily A member 3 (Kv1.3) channel inhibitors. This work continued to show that the human α-defensins human neutrophil peptide (HNP) 1 and human defensin (HD) 5 are selective Kv1.3 channel inhibitors with 50% inhibition concentration values of 102.0 ± 30.3 nM and 2.2 ± 0.2 μM, respectively. Furthermore, HNP1 was found to inhibit Kv1.3 currents and IL-2 secretion in human CD3(+) T cells. Despite the structural similarity between HNP1 and HD5, HNP1 could simultaneously bind to the S1-S2 linker and the pore region of the Kv1.3 channel as both a toxinlike blocker and a novel modifier, whereas HD5 could only bind to the channel pore region as a toxinlike blocker. As a channel modifier, HNP1 could shift the conductance-voltage relationship curve of the Kv1.3 channel by ∼9.5 mV in the positive direction and could increase the time constant for channel activation through the electrostatic repulsion between the cationic HNP1 anchored in the S1-S2 linker and the positively charged S4 domain of the Kv1.3 channel. Together, these findings reveal that human α-defensins are novel endogenous inhibitors of Kv1.3 channels with distinct interaction mechanisms, which facilitates future research into their adaptive immune functions. © FASEB.

Entities:  

Keywords:  HD5; HNP1; immune modulation; interaction mechanism; potassium channel modifier

Mesh:

Substances:

Year:  2015        PMID: 26148969     DOI: 10.1096/fj.15-274787

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.

Authors:  Lanxia Meng; Zili Xie; Qian Zhang; Yang Li; Fan Yang; Zongyun Chen; Wenxin Li; Zhijian Cao; Yingliang Wu
Journal:  J Biol Chem       Date:  2016-01-27       Impact factor: 5.157

2.  Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.

Authors:  Austin B Schwartz; Anshika Kapur; Wentao Wang; Zhenbo Huang; Erminia Fardone; Goutam Palui; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

3.  The role of biomarkers in the diagnosis of periprosthetic joint infection.

Authors:  AliSina Shahi; Javad Parvizi
Journal:  EFORT Open Rev       Date:  2017-03-13

4.  Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo.

Authors:  Xiao Wang; Xiumin Wang; Da Teng; Ruoyu Mao; Ya Hao; Na Yang; Zhanzhan Li; Jianhua Wang
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

5.  Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels.

Authors:  Yaoyun Zhang; Yonghui Zhao; Hongyue Liu; Weiwei Yu; Fan Yang; Wenhua Li; Zhijian Cao; Yingliang Wu
Journal:  Molecules       Date:  2018-06-20       Impact factor: 4.411

6.  Centipede KCNQ Inhibitor SsTx Also Targets KV1.3.

Authors:  Canwei Du; Jiameng Li; Zicheng Shao; James Mwangi; Runjia Xu; Huiwen Tian; Guoxiang Mo; Ren Lai; Shilong Yang
Journal:  Toxins (Basel)       Date:  2019-02-01       Impact factor: 4.546

Review 7.  Review on Biological Characteristics of Kv1.3 and Its Role in Liver Diseases.

Authors:  Junda Liu; Xiong-Wen Lv; Lei Zhang; Hua Wang; Jun Li; Baoming Wu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

8.  Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.

Authors:  Ning Zhao; Qian Dong; Cheng Qian; Sen Li; Qiong-Feng Wu; Dan Ding; Jing Li; Bin-Bin Wang; Ke-fang Guo; Jiang-jiao Xie; Xiang Cheng; Yu-Hua Liao; Yi-Mei Du
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

Review 9.  Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities.

Authors:  Anna J Battersby; Jasmeet Khara; Victoria J Wright; Ofer Levy; Beate Kampmann
Journal:  Front Immunol       Date:  2016-08-18       Impact factor: 7.561

10.  Antimicrobial Mechanism of pBD2 against Staphylococcus aureus.

Authors:  Kun Zhang; Heng Zhang; Chunyu Gao; Ruibo Chen; Chunli Li
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.